Multiple Assemblies exist for SMTL entry 1nd3
The structure of HRV16, when complexed with pleconaril, an antiviral compound; X-RAY DIFFRACTION 2.80 Å

	SMTL ID 1nd3.1 Ligands ZINC ION; 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE Polypeptides coat protein VP1; coat protein VP2; coat protein VP3; coat protein VP4 Oligo-state hetero-oligomer
	SMTL ID 1nd3.2 Ligands ZINC ION; 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE Polypeptides coat protein VP1; coat protein VP2; coat protein VP3; coat protein VP4 Oligo-state hetero-oligomer
	SMTL ID 1nd3.3 Ligands ZINC ION; 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE Polypeptides coat protein VP1; coat protein VP2; coat protein VP3; coat protein VP4 Oligo-state hetero-oligomer
	SMTL ID 1nd3.4 Ligands ZINC ION; 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE Polypeptides coat protein VP1; coat protein VP2; coat protein VP3; coat protein VP4 Oligo-state hetero-oligomer